Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Cost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Milestone Scientific (MLSS) Cost of Revenue (2016 - 2025)

Milestone Scientific (MLSS) has disclosed Cost of Revenue for 16 consecutive years, with $556313.0 as the latest value for Q4 2025.

  • Quarterly Cost of Revenue rose 10.72% to $556313.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.6 million through Dec 2025, up 16.9% year-over-year, with the annual reading at $2.6 million for FY2025, 16.9% up from the prior year.
  • Cost of Revenue hit $556313.0 in Q4 2025 for Milestone Scientific, down from $719247.0 in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $1.2 million in Q4 2022 to a low of $442560.0 in Q2 2024.
  • Historically, Cost of Revenue has averaged $784682.0 across 5 years, with a median of $733622.0 in 2021.
  • Biggest five-year swings in Cost of Revenue: surged 1799.08% in 2021 and later tumbled 56.61% in 2024.
  • Year by year, Cost of Revenue stood at $1.1 million in 2021, then grew by 8.43% to $1.2 million in 2022, then plummeted by 35.11% to $750102.0 in 2023, then plummeted by 33.02% to $502452.0 in 2024, then increased by 10.72% to $556313.0 in 2025.
  • Business Quant data shows Cost of Revenue for MLSS at $556313.0 in Q4 2025, $719247.0 in Q3 2025, and $705860.0 in Q2 2025.